XOMA Royalty (XOMA) Debt to Equity (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Debt to Equity came in at $1.11 in Q1 2026, down 37.04% year-on-year from $1.76 in Q1 2025, and down 14.71% quarter-over-quarter from $1.3 in Q4 2025.

XOMA Royalty (XOMA) Debt to Equity (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Debt to Equity across 16 years of filings, most recently posting $1.11 for Q1 2026.

  • Debt to Equity for Q1 2026 came in at $1.11, down 37.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.11 (down 37.04% YoY), and the FY2025 annual result was $1.3, down 32.05% from the prior year.
  • Debt to Equity came in at $1.11 for Q1 2026 at XOMA Royalty, down from $1.3 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.94 in Q1 2024 to a low of $1.11 in Q1 2026.
  • The 4-year median for Debt to Equity is $1.67 (2025), against an average of $1.6.
  • Across the five-year window, Debt to Equity climbed 5.8% in 2024 and tumbled 37.04% in 2026, its largest moves.
  • XOMA Royalty's Debt to Equity stood at $1.81 in 2023, then advanced by 5.8% to $1.91 in 2024, then sank by 32.05% to $1.3 in 2025, then fell by 14.71% to $1.11 in 2026.
  • The last three Debt to Equity figures came in at $1.11 (Q1 2026), $1.3 (Q4 2025), and $1.24 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn -
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - 1.11

Historic Data

Download Data
DateValue
Mar 31, 2026 1.11
Dec 31, 2025 1.30
Sep 30, 2025 1.24
Jun 30, 2025 1.57
Mar 31, 2025 1.76
Dec 31, 2024 1.91
Sep 30, 2024 1.82
Jun 30, 2024 1.51
Mar 31, 2024 1.94
Dec 31, 2023 1.81
Mar 31, 2021 0.23
Dec 31, 2020 0.24
Sep 30, 2020 0.79
Jun 30, 2020 0.81
Mar 31, 2020 0.77
Dec 31, 2019 0.73
Sep 30, 2019 1.27
Jun 30, 2019 1.24
Mar 31, 2019 0.94
Dec 31, 2018 1.20